Neuropsychiatric Disorders: Pharmacological Aspects
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 February 2026 | Viewed by 1312
Special Issue Editor
2. CENEMED Platform for Interdisciplinary Research, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania
Interests: neurophysiology; neurodegeneration; animal behaviour; molecular biology; molecular genetics; oxidative stress
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
As the Guest Editor of Pharmaceuticals, I am happy to invite you to contribute to this Special Issue, aimed at gathering relevant and good-quality scientific information, and facilitating communication between experts in the fields of neuropsychiatry, neurophysiology and pharmacology concerning innovative therapeutical measures in neuropsychiatric disorders. The interest of the current Special Issue is mainly focused on neuropsychiatry, but we also encourage interdisciplinary approaches, as well as fundamental research, with both animal studies and patient studies being welcome. The pharmacological aspects and inter-relations between pathological mechanisms and drug response could address any neuropsychiatric disorder, as defined by the DSM-V, and any known comorbidities, including cardiovascular disorders, coagulopathies and gastrointestinal disorders (including, but not limited to microbiome–gut–brain axis impairments).
We invite authors to contribute original research papers and reviews.
Dr. Ioana-Miruna Balmus
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuropsychiatric disorders
- DSM-V
- pharmacodynamics
- innovative therapies
- animal models
- neuropsychiatric patients
- trauma and stress
- neurodegeneration
- affective disorders
- neurodevelopmental disorders
- schizophrenia
- sleep disorders
- comorbidities
- cardiovascular
- coagulopathies
- gastrointestinal
- microbiome–gut–brain axis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
